Research & Development Market Research Reports & Industry Analysis
New product design and development is essential for the survival and growth of many companies, as markets and consumers’ tastes are fickle and the competition can be fierce. In order to stay relevant in a fast changing marketplace, firms have to constantly revise and expand their range of product offerings. Therefore, research and development is of great economic importance as companies fight to maintain their market share, though it may mean forgoing current profits in favor of potential future performance and returns.
Research and development is most often associated with the technology industry, as well as with science and in particular with healthcare and the development of new pharmaceuticals, diagnostics or medical devices that are safe and effective. For instance, drug makers must constantly search for the next big blockbuster drug, since the products they currently have on the market will eventually lose their patent protection and be vulnerable to generic competition. So they spend huge amounts of money on R&D because without a promising drug pipeline their revenue stream will ultimately dry up.
Filter your search
Research Assistance
Research & Development Industry Research & Market Reports
-
Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) - Pipeline Review, H1 2018
... molecules. Out of which approximately 8 molecules are developed by companies and remaining by the universities/institutes. The latest report Heparanase - Pipeline Review, H1 2018, outlays comprehensive information on the Heparanase (Endo Glucoronidase or Heparanase ... Read More
-
Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) - Pipeline Review, H1 2018
... 'Glucosylceramidase - Pipeline Review, H1 2018'; Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) pipeline Target constitutes close to 14 molecules. ... Read More
-
Insomnia - Pipeline Review, H1 2018
... Insomnia is a sleep disorder that is characterized by difficulty falling and/or staying asleep. Symptoms include difficulty falling asleep at night, irritability, depression or anxiety, tension headaches and distress in the stomach and intestines. Risk ... Read More
-
Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H1 2018
... 2018'; Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) pipeline Target constitutes close to 9 molecules. Out of which approximately 9 molecules are developed by Companies. Interleukin 2 Receptor Subunit ... Read More
-
Hypertrophic Cardiomyopathy - Pipeline Review, H1 2018
... landscape. Hypertrophic cardiomyopathy (HCM) is a disease in which the heart muscle (myocardium) becomes abnormally thick (hypertrophied). The thickened heart muscles make it harder for the heart to pump blood. Symptoms include chest pain, especially ... Read More
-
Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Pipeline Review, H1 2018
... pipeline Target constitutes close to 12 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes. The latest report Islet Amyloid Polypeptide - Pipeline Review, H1 2018, outlays comprehensive ... Read More
-
Behcet Disease - Pipeline Review, H1 2018
... landscape. Behcet disease (BEH-chets), sometimes called Behcet syndrome, Morbus Behçet, or Silk Road disease, is a rare immune-mediated systemic vasculitis. The more common symptoms include sores in the mouth and on the genitals(sex organs). More ... Read More
-
Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H1 2018
... Associated Protein 2 or TERT or EC 2.7.7.49) pipeline Target constitutes close to 32 molecules. Out of which approximately 28 molecules are developed by companies and remaining by the universities/institutes. The latest report Telomerase Reverse ... Read More
-
Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA or CD137 or TNFRSF9) - Pipeline Review, H1 2018
... Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA or CD137 or TNFRSF9) - Tumor necrosis factor receptor superfamily member 9 (TNFRSF9), also known as CD137 ... Read More
-
Glycoprotein 41 (gp41) - Pipeline Review, H1 2018
... of which approximately 13 molecules are developed by companies and remaining by the universities/institutes. Glycoprotein 41 (gp41) - Gp41 or glycoprotein 41 is a transmembrane protein that contains several sites within its ectodomain that are ... Read More
-
Catenin Beta 1 (Beta Catenin or CTNNB1) - Pipeline Review, H1 2018
... gene. In the presence of Wnt ligand, CTNNB1 acts as a coactivator for transcription factors of the TCF/LEF family, leading to activate Wnt responsive genes. It is involved in the regulation of cell adhesion, CDK2/PTPN6/CTNNB1/CEACAM1 ... Read More
-
Cytochrome P450 11B2 Mitochondrial (Aldosterone Synthase or Cytochrome P450Aldo or Cytochrome P450C18 or Steroid 18 Hydroxylase or CYP11B2 or EC 1.14.15.4 or EC 1.14.15.5) - Pipeline Review, H1 2018
... published report 'Cytochrome P450 11B2 Mitochondrial - Pipeline Review, H1 2018'; Cytochrome P450 11B2 Mitochondrial (Aldosterone Synthase or Cytochrome P450Aldo or Cytochrome P450C18 or Steroid 18 Hydroxylase or CYP11B2 or EC 1.14.15.4 or EC 1.14.15.5) ... Read More
-
Alpha Galactosidase A (Alpha D-Galactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22) - Pipeline Review, H1 2018
... D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22) - Alpha Galactosidase A (Alpha D-Galactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22) pipeline Target ... Read More
-
Ventricular Tachycardia - Pipeline Review, H1 2018
... landscape.Ventricular tachycardia is avery fast heart rhythm that begins in the ventricles. Symptoms of ventricular tachycardia include dizziness, fainting, fatigue, chest pain and shortness of breath. Causes include cardiomyopathy, ischemic heart disease and heart failure. ... Read More
-
Scientific Research & Development in the US - Industry Market Research Report
... line with an expanding economy. Though budget sequestration and further governmental funding declines harmed operators by reducing revenue from an important source of demand, the industry performed well as a result of its transition toward ... Read More
-
Analyzing the Global CNS Market 2018
... despite the relatively high risks associated with product development. This is largely due to significant levels of unmet medical need and the clinical specificity of many CNS drugs. The CNS disorders market may be segmented ... Read More
-
Japan Duchenne Muscular Dystrophy Market Research Report 2018
... this report analyzes the top manufacturers in Japan and major regions, and splits the Duchenne Muscular Dystrophy market by product type and applications/end industries. The major players in Japan Duchenne Muscular Dystrophy market include PTC ... Read More
-
Drugs for Neglected Diseases initiative - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
... business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Drugs for Neglected Diseases initiative since January2007. Synopsis Marketline's Company Mergers & Acquisitions (M&A), ... Read More
-
Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report
... intensifying market competition. In response, many brand name manufacturers expanded their product portfolios to include biotechnology, particularly biologic drugs. This class of drugs is driven by innovation and typically benefits from greater patent protection. While ... Read More
-
Global Psoriasis Pipeline Drugs Market Research Report 2018
... market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Psoriasis Pipeline Drugs basics: ... Read More
-
Human Parainfluenza Virus 3 Infections - Pipeline Review, H1 2018
... of the Human Parainfluenza Virus 3 Infections (Infectious Disease) pipeline landscape. Human parainfluenza virus 3 is a life-threatening infection that causes respiratory illnesses in infants and young children. Symptoms include fever, cough, runny nose, croup, ... Read More
-
Cathepsin S (CTSS or EC 3.4.22.27) - Pipeline Review, H1 2018
... Companies. The latest report Cathepsin S (CTSS or EC 3.4.22.27) - Pipeline Review, H1 2018, outlays comprehensive information on the Cathepsin S (CTSS or EC 3.4.22.27) targeted therapeutics, complete with analysis by indications, stage of ... Read More
-
Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 (GABA(A) Receptor Subunit Gamma 2 or GABRG2) - Pipeline Review, H1 2018
... H1 2018'; Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 (GABA(A) Receptor Subunit Gamma 2 or GABRG2) pipeline Target constitutes close to 7 molecules. Out of which approximately 5 molecules are developed by companies and remaining by ... Read More
-
Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H1 2018
... antecedent is the zymogen form of factor Xia. Factor XI triggers the middle phase of the intrinsic pathway of blood coagulation by activating factor IX. Inhibitors of factor XIa include protein Z-dependent protease inhibitor. Coagulation ... Read More
-
100+ Companies in Contract Pharmaceutical Research - White Paper
... website and address is provided for each company. The White Paper does not detail companies or discuss the CRO marketplace - for this purpose, please consult our recent report, Outsourcing in Drug Discovery, 8th Edition. Read More
